-+ 0.00%
-+ 0.00%
-+ 0.00%
TATA Health (01255) estimates that shareholders should account for a loss of approximately HK$12.399 million in the interim
Share
Listen to the news

According to the Zhitong Finance App, TATA Health (01255) issued an announcement. It is expected that the Group will obtain losses attributable to the company owners of about HK$12.399 million in the six months ending June 30, 2026, while in the same period in 2025, profit attributable to the company owners is approximately HK$20.596 million. The Board of Directors believes that the profit attributable to the owners of the company changed from profit to loss during the reporting period, mainly due to a one-time income of about HK$34.7 million from the sale of subsidiaries in the same period in 2025. However, no proceeds relating to the sale of subsidiaries were obtained during the reporting period, which led to losses during the reporting period.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending